Inovio Pharmaceuticals (INO)

Add to Watchlists
Create an Alert
2.52 -0.15  -5.62% AMEX Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
INO Price Chart
View All Events

INO Events

Date Type Description
Nov 12 Misc Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results Conference Call
Nov 12 Earnings Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013. Estimate: -0.03.
Sep 10 Misc Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership With Roche
Aug 09 Earnings Inovio Pharmaceuticals Reports 2013 Second Quarter Financial Results. Estimate: -0.02.
May 17 Misc AGM Event for Inovio Pharmaceuticals Inc
May 10 Earnings Inovio Pharmaceuticals Reports 2013 First Quarter Financial Results. Estimate: -0.05.
View All Performance Charts

INO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Inovio Pharmaceuticals is up 344.1% over the last year vs S&P 500 Total Return up 23.54%, Cambrex up 72.88%, and Actelion up 72.03%.

Get Quote for

PDF Report for INO

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download INO Pro Report PDF

Portfolio Strategies Featuring INO

Did Inovio Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Pennsylvania
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Inovio Pharmaceuticals, Inc. is a biomedical company, engaged in the development of next-generation vaccines to prevent or treat cancers and chronic infectious diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
INO 2.52 -0.15 -5.62% 532.74M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.